REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 182 filers reported holding REGENXBIO INC in Q3 2022. The put-call ratio across all filers is 0.65 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2023 | $889,405 | +11.3% | 49,549 | +2.0% | 0.17% | 0.0% |
Q3 2023 | $799,281 | -9.3% | 48,559 | +10.1% | 0.17% | -2.8% |
Q2 2023 | $881,679 | +92.1% | 44,106 | +81.7% | 0.18% | +33.3% |
Q1 2023 | $459,059 | -24.1% | 24,276 | -9.0% | 0.13% | -77.5% |
Q4 2022 | $605,216 | -15.9% | 26,685 | -2.1% | 0.59% | -11.2% |
Q3 2022 | $720,000 | -3.6% | 27,259 | -9.9% | 0.66% | +16.4% |
Q2 2022 | $747,000 | -30.6% | 30,251 | -6.8% | 0.57% | +11.8% |
Q1 2022 | $1,077,000 | -13.9% | 32,460 | -15.1% | 0.51% | +11.6% |
Q4 2021 | $1,251,000 | – | 38,253 | – | 0.46% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 847,424 | $13,948,599 | 12.64% |
Sonic GP LLC | 518,079 | $8,527,580 | 8.28% |
MPM BioImpact LLC | 656,718 | $10,809,578 | 2.89% |
Redmile Group, LLC | 2,574,042 | $42,368,731 | 2.02% |
ArchPoint Investors | 224,278 | $3,691,616 | 1.41% |
WS MANAGEMENT LLLP | 618,131 | $10,174,436 | 0.82% |
Redwood Wealth Management Group, LLC | 14,360 | $236,366 | 0.28% |
HARBOR CAPITAL ADVISORS, INC. | 48,559 | $799,281 | 0.17% |
PRENTISS SMITH & CO INC | 11,240 | $185,010 | 0.14% |
LIBERTY ONE INVESTMENT MANAGEMENT, LLC | 36,522 | $601,152 | 0.09% |